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The extracts and fractions from the flowers of A. podalyriifolia were analyzed previously for antibacterial 
activity using diffusion in disk, Antioxidant properties were evaluated by determining radical scavenging 
power (DPPH test) and total phenol content was measured (Folin method). The present study describes 
the in vitro antibacterial (determining minimum inhibitory concentration) and antioxidant activities (by 
thiobarbituric acid reactive species – TBARS method) for the ethanol extract, dichloromethane and 
ethyl acetate fractions and two flavanones (naringenin and 5-β-D-glycosyl-naringenin) isolated from the 
flowers of Acacia podalyriifolia A. Cunn. ex G. Don. The flavanones naringenin and 5-β-D-glycosyl-
naringenin had not previously been obtained from this species. The most effective antibacterial activity 
was observed in the ethyl acetate fraction (MIC=0.25 mg mL-1 against Staphylococcus aureus ATCC 6538, 
MIC = 0.125 mg mL-1 against Staphylococcus epidermidis ATCC 12229, MIC=0.5 mg mL-1 against 
Streptococcus pyogenes ATCC 19615, Klebsiella pneumoniae ATCC 13883 and Proteus mirabilis ATCC 
43071). The evaluated samples showed antioxidant activity on the TBARS test, especially for ethanol 
extract (1000 ppm), which was the most active (29.43% ± 0.65) followed by ethyl acetate fraction 
(1000 ppm, 24.84% ± 1,28), both demonstrating higher activity than that presented by ascorbic acid 
(1000 ppm, 21.73% ± 1.77), although lower than the BHT (1000 ppm 35.15% ± 3.42), both reference 
compounds. Naringenin and 5-β-D-glycosyl-naringenin demonstrated antioxidant action, but only 
naringenin inhibited the growth of gram-positive and gram-negative bacteria.
Uniterms: Acacia podalyriifolia/qualitative analysis. Acacia podalyriifolia/phytochemistry. Acacia 
podalyriifolia/antibacterial activity. Acacia podalyriifolia/antioxidant properties. Flavanones. 5-b-D-
glycosyl-naringenin. Naringenin.
Os extratos e frações de Acacia podalyriifolia foram analisados previamente para a atividade antibacteriana 
através da difusão em disco e as propriedades antioxidantes foram verificadas pela determinação da 
capacidade removedora do radical livre DPPH e pela mensuração do conteúdo de fenólicos totais (Método 
de Folin). O presente estudo descreve as atividades antibacteriana (determinação da concentração inibitória 
mínima) e antioxidante (espécies reativas do ácido tiobarbitúrico – teste TBARS) para o extrato etanólico 
e as frações diclorometano e acetato de etila e para duas flavanonas (naringenina e 5-b-D-glicosil-
naringenina) isoladas das flores de Acacia podalyriifolia A. Cunn. ex G. Don. As flavanonas naringenina 
e 5-b-D-glicosil-naringenina ainda não haviam sido obtidas desta espécie. A atividade antibacteriana mais 
efetiva foi observada com a fração acetato de etila (CIM=0,25 mg/mL contra Staphylococcus aureus 
ATCC 6538; CIM=0,125 mg/mL, contra Staphylococcus epidermidis ATCC 12229; CIM=0,5 mg/mL 
contra Streptococcus pyogenes ATCC 19615, Klebsiella pneumoniae ATCC 13883 e Proteus mirabilis 
ATCC 43071). As amostras avaliadas demonstraram atividade pelo teste TBARS, especialmente o extrato 
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etanólico (1000 ppm), que foi o mais ativo (29,43% ± 0.65), seguido pela fração acetato de etila (1000 ppm, 
24,84% ± 1,28), ambos demonstrando atividade mais elevada que a apresentada pelo ácido ascórbico (1000 
ppm, 21,73% ± 1,77), ainda que menor que a do BHT (1000 ppm, 35,15% ± 3,42), ambas substâncias de 
referência. Naringenina e 5-b-D-glicosil-naringenina demonstraram ação antioxidante, porém somente 
a naringenina inibiu o crescimento de bactérias gram-positivas e gram-negativas. 
Unitermos: Acacia podalyriifolia/análise qualitativa. Acacia podalyriifolia/atividade antibacteriana. 
Acacia podalyriifolia/propiedades antioxidantes. Flavanonas. 5-b-D-Glicosil-naringenina. Naringenina.
INTRODUCTION
Acacia podalyriifolia A. Cunn. Ex G. Don, Legu-
minosae-Mimosoideae, is an exotic plant cultivated in 
the south of Brazil as an ornamental tree (Burkart, 1979). 
Several species in the gender Acacia present important 
medicinal applications (Hagos, Samuelsson, 1988; 
Chhabra et al., 1990; Nabi et al., 1992; Sekine et al., 1997; 
Kambizi, Afolayan, 2001; Saleem et al., 2001; Andrade 
et al., 2003; Meera et al., 2005; Wu et al., 2005) and pos-
sess phenolic compounds, for which countless biological 
activities are described (Kerber, Silva, 1993; Andrade et 
al., 2003; Meera et al., 2005). However, to date, studies of 
A.podalyriifolia are scarce (White, 1943; Ballandrin et al., 
1978; Anderson, Bell, 1976; Churms et al.,1970; Andrade 
et al., 2003; Andrade et al., 2005; Andrade et al., 2007), 
motivating research on this species.
The extracts and fractions from A. podalyriifolia 
were analyzed previously for antibacterial and antioxi-
dant actions and have demonstrated activities. For the 
evaluation of the antibacterial action, a selection was 
made against two gram-positive and two gram-negative 
bacteria, using the diffusion in disk (Andrade et al, 2005). 
The antioxidant action was verified with the free radical 
2,2-diphenyl-1-picrylhydrazyl (DPPH) (Andrade et al., 
2007).
Previous results from this study have shown that 
determination of the minimum inhibitory concentration 
(MIC), adapted from Brasileiro et al. (2006) with modifi-
cations, allows quantitative estimation of the antibacterial 
activity. For this test, several sequential dilutions of the 
samples with antibacterial activity were incorporated into 
the medium, added to the bacterium and incubated for 24 
hours. MIC is the lowest concentration of antibacterial 
agent that is capable of inhibiting the growth of the mi-
croorganism in vitro (Brasileiro et al., 2006).
Lipid peroxidation, which occurs by increased oxi-
dative stress caused by reactive oxygen species (ROS), is 
a known mechanism of cellular damage that contributes 
to aging and many pathological processes such as chronic 
inflammation, respiratory disorders, neurodegenerative 
diseases, diabetes mellitus , atherosclerosis, autoimmu-
ne diseases of the endocrine glands and carcinogenesis 
(Dawn-Linsley et al., 2005; Chanwitheesuk et al., 2005; 
Andrade et al., 2007).
Antioxidants are substances that can significantly 
delay or prevent the oxidation of substrates as well as pre-
vent or repair damage caused to cells by reactive oxygen 
species (Chanwitheesuk et al., 2005). 
TBARS assays measure the end-point oxidative 
damage, being useful to evaluate the effects of induced 
oxidative stress and protection from lipid peroxidation by 
antioxidants which may be present in the analyzed material 
(Dawn-Linsley et al., 2005).
MATERIAL AND METHODS
Flowers of A. podalyriifolia were collected in Curi-
tiba – Brazil, from June to September, 2007. The material 
was identified by the botanist Gert Hatschbach of the Mu-
nicipal Botanical Museum of Curitiba and the exsiccate 
deposited under the number 268.219.
After drying in the shade, 300 g of flowers of A. 
podalyriifolia were submitted to ethanol extraction, 
following by liquid-liquid partition with hexane, dichlo-
romethane and ethyl acetate, using Sohxlet, as per me-
thodology described in previous studies (Andrade et al., 
2005; Andrade et al., 2007; Carvalho et al., 2009). After 
the evaporation of the solvents under reduced pressure and 
temperature of 40 ºC, a 0.7 g of dichloromethane fraction 
and 6.3 g of ethyl acetate fraction were obtained.
The dichloromethane fraction (0.5 g) was submitted 
to chromatography in a column of silicagel 60 (0.063 to 
0.200 mm) Merck® with a mixture of solvents, beginning 
with hexane, followed by gradually increasing polarity 
(hexane:ethyl acetate and ethyl acetate:methanol). The 
crystallization obtained among the sub-fractions 19 to 
57 (142.2 mg) and subsequent analysis by thin-layer 
chromatography (Aluminum Sheet F254 - Merck®) with 
mobile phase chloroform:methanol (90:10), demonstrated 
a mixture of compounds that were gathered and submitted 
to chromatographic separation in a column of silicagel 60 
(0.063 to 0.200 mm) Merck® with the same sequence of 
previous solvents. Crystals in yellow needles (15.2 mg), 
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were obtained corresponding to the group of sub-fractions 
2 to 4, designated as substance 1.
Also, the ethyl acetate fraction (5 g) was submitted 
to chromatographic separation in a column of silicagel 60 
(0.063 to 0.200 mm) Merck® with a mixture of solvents, 
beginning with ethyl acetate 100%, followed by gradually 
increasing polarity (ethyl acetate:formic acid and ethyl 
acetate:methanol:water:formic acid), yielding crystals in 
white needles (482 mg), corresponding to the group of 
sub-fractions 20-33, designated as substance 2.
Substances 1 and 2 were exposed to ultraviolet (200-
400 nm) using the reagents diagnoses, according to Mabry 
et al. (1970), 1H RMN (300 MHz CD CDCl3), 
13C NMR 
(300 MHz CDCl3) and Infrared (400-4000 cm
-1). Substan-
ce 2 hydrolized with trifluoroacetic acid 4N (TFA), follo-
wing thin-layer chromatography (Aluminum Sheet F254 
- Merck®) with mobile phase isopropanol:ethyl acetate: 
nitroethane:water (30:5:5:5), and the standard monosac-
charides (glucose, galactose, rhamnose, mannose, xylose) 
and naringenin, using orcinol 1% in methanol:H2SO4 
(90:10), with heating as disclosed. For substance 1, thin-
layer chromatography was performed with authentic 
sample of naringenin and chloroform: methanol (90:10) 
as mobile phase.
Naringenin (1): crystals in yellow needles, 3.04% 
of production in relation to the dichloromethane frac-
tion (0.0071% in relation to the initial material); M.P. 
250-252 ºC, HRMS (CIMS) m/z: 294.5 [M + Na]+ 
(272.068 made calculations for C15H12O5); IR (KBr) 
3035-3280 (O-H), 2831-2976 (C-H), 1639 (C=O), 1602 
(C=C), 1313-1520 (C-OH), UV lmax (MeOH) 288 (3.92), 
320 (sh) (3.58), (NaOMe) 244 (4.00), 322 (4.18), (NaOAc) 
251 (3.43), 320 (4.05), (NaOAc/H3BO3) 291 (4.06), 320 
(3.27), (AlCl3) 310 (4.04), 363 (3.20), (AlCl3 / HCl) 311 
(4.11), 371 (3.41) nm (log ε); 1H NMR (300 MHz CD3OD) 
δ 2.99 (1H, dd, J 1.8, 9.6 Hz, H-3α), 3.03 (1 H, dd, J 9.6, 
12.6 Hz, H-3β), 5.24 (1H, dd, J 1.8, 9.6 Hz, H-2α), 5.81 
(2H, s, H-6, 8), 6.74 (2H, d, J 6.5 Hz, H-3’, 5’), 7.23 (2H, 
d, J 6.5 Hz, H-2’, 6’); 13C NMR (100 MHz CD3OD) δ 
44.05(C-3), 80.50 (C-2), 96.21 (C-6), 97.09 (C-8), 103.37 
(C-10), 116.36 (C-3’, C-5’), 129.07 (C-2’, C-6’), 131.10 
(C-1’), 159.02 (C-4’), 165.47 (C-5), 168.39 (C-7), 164.90 
(C-9), 197.81 (C-4).
5-b-D-glycosyl-naringenin (2): crystals in white 
needles, 9.64% of production in relation to the ethyl acetate 
fraction (0.2% in relation to the initial; M.P. 172-173 ºC; 
[α]20D - 121º (c 1.3, MeOH); HRMS (CIMS) m/z: 457.1187 
[M.+ Na]+ (434.1213 made calculation for C21H22O10); IR 
(KBr) 3362(O-H), 2891-2978 (C-H), 1685 (C=O), 1585-
1646 (C=C), 1458-1531 (C-OH), UV lmax (MeOH): 283 
(4,11), 320 (sh) (3.78), (NaOMe): 249 (4.02), 325 (4.31); 
(NaOAc): 252 (4.02), 325 (4.31); (NaOAc/H3BO3): 283 
(4.15), 321 (sh) (3.88); (AlCl3): 226 (4.36), 283 (4.15), 
320 (sh) (3.83); (AlCl3/HCl): 226 (4.34), 283 (4.11), 320 
(sh) (3.81); nm (log ε); 1H NMR (300 MHz CD3OD) δ 
2.56 (1H, dd, J 2.7, 17.10 Hz, H-3α), 2.99 (1 H, dd, J 12.9, 
17.10 Hz, H-3β), 3.47 a 3.53 (4H of the glucose, m, H-2’’, 
3’’, 4’’, 5’’), 3.71 (1H, d, J 7.2 Hz, H-6’’α), 3.73 (1H, d, J 
7.2 Hz, H-6’’β), 4.67 (1H, d, J 7.5 Hz, H-1’’), 5.33 (1H, 
dd, J 2.7, 12.9 Hz, H-2α), 6.06 (1H, d, J 2.1 Hz, H-6), 6.37 
(1H, d, J 2.1 Hz, H-8), 6.75 (2H, dd, J 2.7, 8.4 Hz, H-3’, 
5’), 7.26 (2H, dd, J 6.0, 8.7 Hz, H-2’, 6’); 13C NMR (300 
MHz CD3OD) δ 44.51(C-3), 60.69 (C-6’’), 69.61 (C-4’’), 
73.47 (C-2’’), 75.57 (C-5’’), 77.57 (C-3’’), 78.16 (C-2), 
97.78 (C-8), 98.96 (C-6), 103.49 (C-1”), 105.38 (C-10), 
115.15 (C-3’, C-5’), 128.33 (C-2’, C-6’), 128.98 (C-1’), 
157.69 (C-4’), 160.74 (C-5), 164.24 (C-7), 165.14 (C-9), 
190.10 (C-4).
Antioxidant activity: The samples obtained from 
the flowers of Acacia podalyriifolia (ethanol extract, 
dichloromethane and ethyl acetate fractions and isolated 
substances naringenin and 5-β-D-glycosyl-naringenine) 
were submitted to the antioxidant test thiobarbituric acid 
reactive species, using concentrations of 100, 500 and 
1000 ppm (parts per million), according to Morais et al. 
(2006) with modifications. Ascorbic acid and BHT (butyl-
ated hydroxy toluene) were used as reference compounds. 
The whole procedure was performed in triplicate.
A 0.5 mL volume of egg yolk solution (10% w/v), 
and 0.1 mL of each sample or reference compound was 
added to test tubes, and the volume completed to 1 mL 
with distilled water. Each of the test tubes then received 
0.05 mL of solution of 2,2’-azobis(2-amidinopropane) 
dihydrochloride - AAPH (0.07 mol/L), 1.5 mL of acetic 
acid 20% (pH 3.5) and 1.5 mL of thiobarbituric acid – TBA 
(0.8% w/v) in solution of sodium dodecil sulfate - SDS 
(1.1% w/v). The material thus prepared was subjected to 
a water bath (95 °C) for 1 hour, while stirring. After cool-
ing, each tube received 5 mL of n-butanol, centrifuged 
for 10 minutes at 3000 rpm, and the supernatants were 
measured by spectrophotometer (Shimadzu) at 532 nm. 
The same process was carried out with control tubes to 
which all reagents were added except the samples.
The antioxidant activity was determined by the An-
tioxidant Index (AI) obtained as a percentage, according 
to the equation: AI (%) = 1 - (A/C) X 100, where A is 
the absorbance of the sample and C is the absorbance of 
fully oxidized control. Results are expressed as mean and 
standard deviation. The statistical examination of the data 
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was performed using the R Project for Statistical Comput-
ing (Gnu Operating System, 2010). Mean values were 
compared by using analysis of the variance (ANOVA) 
test and differences between means were detected using 
Tukey’s test (p < 0.05).
Antibacterial activity: The antibacterial action was 
ascertained by determination of the minimum inhibitory 
concentration (MIC), according to Brasileiro et al. (2006) 
with modifications. The gram - positive strains used were 
Staphylococcus aureus (ATCC 6538), Staphylococcus 
epidermidis (ATCC 12229) and Streptococcus pyogenes 
(ATCC 19615) while the gram-negative strains used were 
Escherichia coli (ATCC 25922), Klebsiella pneumoniae 
(ATCC 13883), Proteus mirabilis (ATCC 43071), Pseu-
domonas aeruginosa (ATCC 27857) and Salmonella ty-
phimurium (ATCC 14028), all acquired by Newprov® in 
liophylized disk. The bacterial suspensions were adjusted, 
using a sterile solution of sodium chloride 0.9%, to con-
form to the turbidity standard 0.5 of the Mac Farland scale 
(108 CFC mL-1), according to the National Committee For 
Clinical Laboratory Standards (1997). A 0.1 mL aliquot of 
bacterial suspension containing 108 CFC mL-1 was mixed 
with 100 mL of sterilized solution of Tween 80 (2%) and 
this mixture was then used in the assay. A sequential dilu-
tion of the samples was used (2, 1, 0.5, 0.25, 0.125 and 
0.075 mg mL-1) and added to test tubes containing 1 mL 
of the TSB (Tryptic Soybean Broth). Subsequently, 1 mL 
of bacterial suspension, previously adjusted, was then 
applied to each tube. The negative control tube contained 
only the microorganisms without the samples, while the 
positive control tube contained the microorganisms and 
chloramphenicol (2 mg mL-1). The whole process was 
repeated twice. The material was incubated to 37 ºC for 
24 hours. The minimum inhibitory concentration was 
defined as the lowest concentration where no microbial 
development occurred, verified by absence of turbidity in 
the tube containing the sample.
RESULTS AND DISCUSSION
The dichloromethane fraction submitted to the 
silicagel column chromatography produced 15.2 mg of 
crystals in the form of needles that had yellow coloration 
(substance 1), while the ethyl acetate fraction produced 
482 mg of crystals in the form of needles with white co-
loration (substance 2).
The structures of the isolated substances were deter-
mined using classic spectroscopic methods (UV, 1H RMN, 
13C RMN, IR and mass spectrometric), analytical thin-
layer chromatography with standards and comparisons to 
the literature (Mabry et al., 1970; Agrawal, 1992; Kerber, 
Silva, 1993; Saito et al., 1994; Ogundaini et al., 1996; 
Zapesochnaya et al., 2002; Morimura et al., 2006), which 
identified substance 1 as naringenin and substance 2 as 
5-β-D-glycosyl-naringenin (Figure 1).
These compounds had not previously been isolated 
from Acacia podalyriifolia, but their presence had been 
noted in the flowers of Acacia longifolia (Kerber, Silva, 
1993). 
The evaluated samples obtained from the flowers 
of A. podalyriifolia showed antioxidant activity on the 
TBARS test, especially for ethanol extract (1000 ppm), 
which was the most active, followed by ethyl acetate 
fraction (1000 ppm), both demonstrating higher activity 
than that presented by reference compounds, ascorbic acid 
(1000 ppm), although were lower than the BHT (1000 ppm). 
Both isolated substances also showed activity, albeit less in-
tense than those reported by their original fractions (Table I).
For the antibacterial activity, absence of turbidity 
in the test tubes containing TSB, sample and appraised 
bacterium, indicates that the sample material at the given 
concentration, showed an inhibitory effect for the growth 
of strains. As demonstrated in Table II, the ethanolic 
extract and the dichloromethane fraction became only 
slightly active, demonstrating inhibition to the strains of 
Staphylococcus aureus and Staphylococcus epidermidis 
with MIC of 1 mg mL-1. The ethyl acetate fraction inhibi-
ted the growth of Staphylococcus epidermidis with MIC 
of 0.125 mg mL -1, Staphylococcus aureus with MIC of 
0.25 mg mL-1, Streptococcus pyogenes, Klebsiella pneu-
moniae and Proteus mirabilis with MIC of 0.5 mg mL-1. 
For isolated substances, there was inhibitory effect only 
with naringenin (MIC of 2 mg mL-1) to Staphylococcus 
aureus, Staphylococcus epidermidis, Klebsiella pneumo-
niae and Proteus mirabilis. 5-β-D-glycosyl-naringenine 
caused no inhibitory effect at the given concentrations.
The results obtained on these tests have demonstra-
ted the ethyl acetate fraction was more active. Although 
the flavanone 5-β-D-glycosyl-naringenin, the substance 
FIGURE 1 - Chemical structure of naringenin (I) and 5-b-D-
glycosyl-naringenin (II).
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TABLE I - Antioxidant Index (%), obtained by TBARS test, of reference compounds and extracts, fractions and isolated substances 
from the flowers of Acacia podalyriifolia A. Cunn. ex G. Don 
Concentration 1000 ppm 500 ppm 100 ppm
Sample AI SD AI SD AI SD
BHT 35.15 3.42 ac 20.25 1.07 bc 10.73 0.59 cab
Ascorbic acid 21.73 1.77 af 14.87 1.44 bd 3.67 0.70 cdef
Ethanol extract 29.43 0.65 acde 18.05 2.01 bcd 13.07 1.91 ca
Ethyl acetate fraction 24.84 1.28 aef 16.45 1.73 bcd 5.98 1.38 ccde
Dichloromethane fraction 19.75 2.31 afg 7.60 1.42 bf 4.55 1.60 ccde
Naringenin 14.60 2.42 ag 8.60 1.31 bef 0.00 0.00 cf
5-β-D-glycosyl naringenin 27.74 2.50 ade 14.19 2.02 bd 1.63 1.55 cef
NOTE: AI = antioxidant index (%), data presented as mean of three experiments with medium values; SD = standard deviation. 
Differences between means indicated by the same letters are not statistically significant (Tukey’s test, p < 0.05).
TABLE II - Antibacterial activity, by determination of MIC, of extracts, fractions and isolated substances from the flowers of Acacia 
podalyriifolia A. Cunn. ex G. Don
SAMPLES 
(mg mL-1)
MIC (mg mL-1)
S. aureus S. epidermidis S. pyogenes E. coli K. pneumoniae P. aeruginosa P. mirabilis S. typhimurium
EE 1 1 >2 >2 >2 >2 >2 >2
DCMF 1 1 >2 >2 >2 >2 >2 >2
EAF 0.25 0.125 0.5 >2 0.5 >2 0.5 >2
NAR 2 2 >2 >2 2 >2 2 >2
NARGLY >2 >2 >2 >2 >2 >2 >2 >2
NOTE: >2 = absence of inhibition, EE = ethanolic extract, DCMF = dichloromethane fraction, EAF = ethyl acetate fraction, 
NAR = naringenin and NARGLY = 5-β- D- glycosyl naringenin, MIC = minimum inhibitory concentration, the lowest concentration 
where no microbial development occurs, verified by absence of turbidity in the tube with the sample.
isolated in greatest abundance from this fraction, has 
demonstrated antioxidant action, it showed no activity 
against the tested bacteria. It is possible that the presence 
of flavonoids and phenolic compounds in the ethyl acetate 
fraction, as demonstrated in the phytochemistry studies 
carried out by Andrade et al. (2003), or a possible syner-
gism among these, could be responsible for the biological 
effects observed with these samples.
The amount of flavonoids 5-β-D-glycosyl-naringenin 
and naringenin in the flowers of A. podalyriifolia 
(2000 µg g-1 and 71 µg g-1, respectively) was considerable. 
Numerous studies describe the pharmacological properties 
of these compounds. Among the several applications of 
these flavanones are an antioxidant effect (Acker, 2000), 
hepatoprotective (Lee et al., 2004; Salgado et al., 2007), 
anti-inflammatory (Bodet et al., 2008), antiviral (Paredes 
et al., 2003; Nahmias et al., 2008), antihypertensive (Sapo-
nara et al., 2006) and antimutagenic (Choi et al., 1994; Re-
nugadevi, Prabu, 2009) effects. These studies demonstrate 
the many potential applications of these compounds, with 
A. podalyriifolia an important source of these substances.
Further investigation of the ethyl acetate fraction 
extracted from the flowers of A. podalyriifolia may yield 
further discoveries.
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